FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

37450811000001105: Femoston-conti 0.5mg/2.5mg tablets (CST Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Aug 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
319621000001112 Femoston-conti 0.5mg/2.5mg tablets (CST Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
319641000001119 Femoston-conti 0.5mg/2.5mg tablets (CST Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Femoston-conti 0.5mg/2.5mg tablets (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Femoston-conti 0.5mg/2.5mg tablets (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Femoston-conti 0.5mg/2.5mg tablets (CST Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Femoston-conti 0.5mg/2.5mg tablets (CST Pharma Ltd) Is a Estradiol 500micrograms / Dydrogesterone 2.5mg tablets true Inferred relationship Existential restriction modifier
Femoston-conti 0.5mg/2.5mg tablets (CST Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Femoston-conti 0.5mg/2.5mg tablets (CST Pharma Ltd) Is a Femoston-conti true Inferred relationship Existential restriction modifier
Femoston-conti 0.5mg/2.5mg tablets (CST Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Femoston-conti 0.5mg/2.5mg tablets (CST Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Femoston-conti 0.5mg/2.5mg tablets (CST Pharma Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Femoston-conti 0.5mg/2.5mg tablets (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Femoston-conti 0.5mg/2.5mg tablets (CST Pharma Ltd) Has specific active ingredient Estradiol true Inferred relationship Existential restriction modifier
Femoston-conti 0.5mg/2.5mg tablets (CST Pharma Ltd) Has specific active ingredient Dydrogesterone true Inferred relationship Existential restriction modifier
Femoston-conti 0.5mg/2.5mg tablets (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Femoston-conti 0.5mg/2.5mg tablets (CST Pharma Ltd) 84 tablet Has AMP True Femoston-conti 0.5mg/2.5mg tablets (CST Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start